The Ferring product portfolio demonstrates an exceptionally innovative and successful track record in the fields of Urology, Endocrine Oncology, Gastroenterology, Endocrinology (Growth) and Reproductive Health (Infertility and Obstetrics).

The common thread is that the Company remains focused on producing treatments that enable doctors to treat patients on the body's own terms.

Today Ferring has developed expertise and technologies that facilitate the use of these compounds, thus capitalising on our strength as a leading company in the field of peptide and protein chemistry.